Mesoblast (MESO) Non-Current Debt (2018 - 2025)

Mesoblast's (MESO) quarterly Non-Current Debt came in at -$149.3 million in Q4 2025, down 7.0% year-on-year from -$160.6 million in Q4 2024, and down 192.43% quarter-over-quarter from $161.6 million in Q2 2025.

Mesoblast (MESO) Non-Current Debt (2018 - 2025) Analysis & Trends

Mesoblast has disclosed Non-Current Debt across 8 years of filings, most recently posting -$149.3 million for Q4 2025.

  • Non-Current Debt for Q4 2025 came in at -$149.3 million, down 7.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$149.3 million (down 7.0% YoY), and the FY2025 annual result was $161.6 million, up 60.77% from the prior year.
  • Non-Current Debt came in at -$149.3 million for Q4 2025 at Mesoblast, down from $161.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $161.6 million in Q2 2025 to a low of -$149.3 million in Q4 2025.
  • The 5-year median for Non-Current Debt is -$37.3 million (2021), against an average of -$14.9 million.
  • Across the five-year window, Non-Current Debt retreated 28.02% in 2021 and surged 123.21% in 2022, its largest moves.
  • Mesoblast's Non-Current Debt stood at $41.0 million in 2021, then tumbled by 381.92% to -$115.7 million in 2022, then fell by 6.29% to -$123.0 million in 2023, then slipped by 13.46% to -$139.5 million in 2024, then declined by 7.0% to -$149.3 million in 2025.
  • The last three Non-Current Debt figures came in at -$149.3 million (Q4 2025), $161.6 million (Q2 2025), and -$139.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - -149.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -149.32 Mn
Dec 31, 2025 -149.32 Mn
Jun 30, 2025 161.55 Mn
Jun 30, 2025 161.55 Mn
Dec 31, 2024 -139.55 Mn
Dec 31, 2024 -139.55 Mn
Jun 30, 2024 100.48 Mn
Jun 30, 2024 100.48 Mn
Dec 31, 2023 -122.99 Mn
Dec 31, 2023 -122.99 Mn
Jun 30, 2023 102.81 Mn
Jun 30, 2023 102.81 Mn
Mar 31, 2023 -119.06 Mn
Mar 31, 2023 -119.06 Mn
Dec 31, 2022 -115.72 Mn
Dec 31, 2022 -115.72 Mn
Jun 30, 2022 91.62 Mn
Jun 30, 2022 91.62 Mn
Jun 30, 2021 41.05 Mn
Jun 30, 2021 41.05 Mn